Citations (173)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (32)
Rodolfo Villena, Paula Kriz, Myint Tin Tin Htar, Cindy Burman, Jamie Findlow, Paul Balmer & Luis Jodar. (2023) Real-world impact and effectiveness of MenACWY-TT. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Litjen (L.J) Tan, Marco Aurelio P. Safadi, Michael Horn, Cristina Regojo Balboa, Elena Moya, Jamie Schanbaum, Pedro Pimenta, Emma Lambert, Lamine Soumahoro, Woo-Yun Sohn, Teresa Bruce & Yara Ruiz García. (2023) Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination. Human Vaccines & Immunotherapeutics 19:1.
Read now
Read now
Ala-Eddine Deghmane & Muhamed-Kheir Taha. (2022) Product review on the IMD serogroup B vaccine Bexsero®. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Mark McMillan, Helen S Marshall & Peter Richmond. (2022) 4CMenB vaccine and its role in preventing transmission and inducing herd immunity. Expert Review of Vaccines 21:1, pages 103-114.
Read now
Read now
Sara Viksmoen Watle, Lisbeth Meyer Næss, Gro Tunheim, Dominique A. Caugant & Torbjørn Wisløff. (2021) Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine. Human Vaccines & Immunotherapeutics 17:8, pages 2777-2787.
Read now
Read now
Liping Huang, Josephine Mauskopf, Ray Farkouh & Catherine Masaquel. (2021) Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada. Expert Review of Vaccines 20:1, pages 59-72.
Read now
Read now
Paul Balmer, Cynthia Burman, Lidia Serra & Laura J. York. (2018) Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature. Human Vaccines & Immunotherapeutics 14:5, pages 1118-1130.
Read now
Read now
Scott Vuocolo, Paul Balmer, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson, John L. Perez & Laura J. York. (2018) Vaccination strategies for the prevention of meningococcal disease. Human Vaccines & Immunotherapeutics 14:5, pages 1203-1215.
Read now
Read now
Andrew Vyse, Gillian Ellsbury & Harish Madhava. (2018) Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Review of Vaccines 17:3, pages 229-237.
Read now
Read now
N. Y. Wang & A. J. Pollard. (2018) The next chapter for group B meningococcal vaccines. Critical Reviews in Microbiology 44:1, pages 95-111.
Read now
Read now
Ray Borrow, Pedro Alarcón, Josefina Carlos, Dominique A. Caugant, Hannah Christensen, Roberto Debbag, Philippe De Wals, Gabriela Echániz-Aviles, Jamie Findlow, Chris Head, Daphne Holt, Hajime Kamiya, Samir K Saha, Sergey Sidorenko, Muhamed-Kheir Taha, Caroline Trotter, Julio A. Vázquez Moreno, Anne von Gottberg & Marco A. P. Sáfadi. (2017) The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Review of Vaccines 16:4, pages 313-328.
Read now
Read now
Win-Yan Chan, Jonathan M Cohen & Jeremy S Brown. (2016) The new first-line defense: the potential of nasopharyngeal colonization in vaccine strategies. Vaccine: Development and Therapy 6, pages 47-57.
Read now
Read now
Roberto Gasparini, Paolo Landa, Daniela Amicizia, Giancarlo Icardi, Walter Ricciardi, Chiara de Waure, Elena Tanfani, Paolo Bonanni, Carlo Lucioni, Angela Testi & Donatella Panatto. (2016) Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis. Human Vaccines & Immunotherapeutics 12:8, pages 2148-2161.
Read now
Read now
Michael Bröker, Francesco Berti & Paolo Costantino. (2016) Factors contributing to the immunogenicity of meningococcal conjugate vaccines. Human Vaccines & Immunotherapeutics 12:7, pages 1808-1824.
Read now
Read now
Cosmina Hogea, Thierry Van Effelterre & Andrew Vyse. (2016) Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement. Human Vaccines & Immunotherapeutics 12:2, pages 451-466.
Read now
Read now
Paul A Kristiansen, Hannah J Jørgensen & Dominique A Caugant. (2015) Serogroup A meningococcal conjugate vaccines in Africa. Expert Review of Vaccines 14:11, pages 1441-1458.
Read now
Read now
Carla D Scarbrough Lefebvre, Augustin Terlinden & Baudouin Standaert. (2015) Dissecting the indirect effects caused by vaccines into the basic elements. Human Vaccines & Immunotherapeutics 11:9, pages 2142-2157.
Read now
Read now
Jian Du, Yuyang Xu, Jun Wang, Shijun Liu, Yan Liu, Xiaoping Zhang & Erping Xu. (2015) 24 year outcomes of hepatitis B vaccination in Hangzhou, China. Human Vaccines & Immunotherapeutics 11:8, pages 2051-2060.
Read now
Read now
Xavier Saez-Llorens, Diana Catalina Aguilera Vaca, Katia Abarca, Emmanuelle Maho, Maria Gabriela Graña, Esther Heijnen, Igor Smolenov & Peter M Dull. (2015) Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents. Human Vaccines & Immunotherapeutics 11:6, pages 1507-1517.
Read now
Read now
Christine S Rollier, Christina Dold, Leanne Marsay, Manish Sadarangani & Andrew J Pollard. (2015) The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy. Expert Opinion on Biological Therapy 15:1, pages 131-142.
Read now
Read now
Marco Aurélio P Sáfadi, Luz Elena Espinosa de los Monteros, Eduardo Luis López, Xavier Sàez-Llorens, Ana Paula Lemos, Sarbelio Moreno-Espinosa, Silvia González Ayala, Juan Pablo Torres, José Cassio de Moraes & Julio Alberto Vázquez. (2013) The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative. Expert Review of Vaccines 12:8, pages 903-915.
Read now
Read now
Koen B. Pouwels, Eelko Hak, Arie van der Ende, Hannah Christensen, Germie P.J.M. van den Dobbelsteen & Maarten J. Postma. (2013) Cost-effectiveness of vaccination against meningococcal B among Dutch infants. Human Vaccines & Immunotherapeutics 9:5, pages 1129-1138.
Read now
Read now
Julie A Bettinger, Shelley L Deeks, Scott A Halperin, Raymond Tsang & David W Scheifele. (2013) Controlling serogroup B invasive meningococcal disease: the Canadian perspective. Expert Review of Vaccines 12:5, pages 505-517.
Read now
Read now
Holly Sanders, Patricia Kaaijk & Germie PJM van den Dobbelsteen. (2013) Preclinical evaluation of MenB vaccines: prerequisites for clinical development. Expert Review of Vaccines 12:1, pages 31-42.
Read now
Read now
Vassiliki Papaevangelou & Nikos Spyridis. (2012) MenACWY-TT vaccine for active immunization against invasive meningococcal disease. Expert Review of Vaccines 11:5, pages 523-537.
Read now
Read now
Andrew R. Gorringe & Rolando Pajón. (2012) Bexsero. Human Vaccines & Immunotherapeutics 8:2, pages 174-183.
Read now
Read now
Marco AP Sáfadi & E David G McIntosh. (2011) Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies. Expert Review of Vaccines 10:12, pages 1717-1730.
Read now
Read now
Montse Soriano-Gabarró, Joanne Wolter, Cosmina Hogea & Andrew Vyse. (2011) Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Expert Review of Anti-infective Therapy 9:9, pages 761-774.
Read now
Read now
Annaliesa S Anderson, Kathrin U Jansen & Joseph Eiden. (2011) New frontiers in meningococcal vaccines. Expert Review of Vaccines 10:5, pages 617-634.
Read now
Read now
Holly Sanders & Ian M Feavers. (2011) Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Review of Vaccines 10:3, pages 323-334.
Read now
Read now
Roberto Gasparini & Donatella Panatto. (2011) Meningococcal glycoconjugate vaccines. Human Vaccines 7:2, pages 170-182.
Read now
Read now
Brian Cooper, Lisa DeTora & Jeffrey Stoddard. (2011) Menveo®: a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y. Expert Review of Vaccines 10:1, pages 21-33.
Read now
Read now
Articles from other publishers (141)
Francesco Tognetti, Massimiliano Biagini, Maxime Denis, Francesco Berti, Domenico Maione & Daniela Stranges. (2023) Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens. International Journal of Molecular Sciences 24:15, pages 12054.
Crossref
Crossref
Fadima C. HaidaraAma UmesiSamba O. SowMagnus OchogeFatoumata DialloAbdulazeez ImamYoussouf TraoreLucy AffleckMoussa F. DoumbiaBubacarr DaffehMamoudou KodioOghenebrume WaririAwa TraoréEdrissa JallowBeate KampmannDhananjay KapsePrasad S. KulkarniAsha MallyaSunil GoelPankaj SharmaAnnamraju D. SarmaNikhil AvalaskarF. Marc LaForceMark R. AldersonAbdi NaficySteve LamolaYuxiao TangLionel MartelletNancy HoskenEvangelos SimeonidisJo Anne WelschMilagritos D. TapiaEd Clarke. (2023) Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia. New England Journal of Medicine 388:21, pages 1942-1955.
Crossref
Crossref
Marcelle Moura Silveira, Pedro Augusto Crespo da Silva, Neida Lucia Conrad, Thaís Larré Oliveira, Daiane Drawanz Hartwig & Caroline Trotter. (2023) Surveillance of invasive meningococcal disease in southern Brazil: considerations of an immunization programme. Journal of Medical Microbiology 72:2.
Crossref
Crossref
Angel Valls-Arévalo, Auxiliadora Fernández de Alba, David López-Martín, Walter Goycochea-Valdivia, Irene Mate-Cano, Marta García-Fernández de Villalta, Ignacio Salamanca de la Cueva & María Garcés-Sánchez. (2023) Historical review of vaccination against meningococcus in Spain (1996–2021). Learned lessons. Vacunas (English Edition) 24:1, pages 45-54.
Crossref
Crossref
Angel Valls-Arévalo, Auxiliadora Fernández de Alba, David López-Martín, Walter Goycochea-Valdivia, Irene Mate-Cano, Marta García-Fernández de Villalta, Ignacio Salamanca de la Cueva & María Garcés-Sánchez. (2023) Revisión histórica de la vacunación frente a meningococo en España (1996-2021). Lecciones aprendidas. Vacunas 24:1, pages 45-54.
Crossref
Crossref
David S. Stephens, Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2023. Plotkin's Vaccines. Plotkin's Vaccines
690
710.e7
.
Mengmeng Yue, Juan Xu, Jianxing Yu & Zhujun Shao. (2022) Carriage prevalence of Neisseria meningitidis in China, 2005–2022: a systematic review and meta-analysis. BMC Infectious Diseases 22:1.
Crossref
Crossref
Edwin J. Asturias, Xilian Bai, Julie A. Bettinger, Ray Borrow, Delia Nais Castillo, Dominique A. Caugant, Grettel Chanto Chacon, Ener Cagri Dinleyici, Gabriela Echaniz-Aviles, Luis Garcia, Linda Glennie, Lee H. Harrison, Rebecca L. Howie, Mark Itsko, Jay Lucidarme, Jose Eduardo Oliva Marin, Henju Marjuki, Lucy A. McNamara, Mustapha M. Mustapha, Joan L. Robinson, Belkis Romeu, Manish Sadarangani, Xavier Sáez-Llorens, Marco A.P. Sáfadi, David S. Stephens, James M. Stuart, Muhamed-Kheir Taha, Raymond S.W. Tsang, Julio Vazquez & Philippe De Wals. (2022) Meningococcal disease in North America: Updates from the Global Meningococcal Initiative. Journal of Infection 85:6, pages 611-622.
Crossref
Crossref
Linda Del Bino, Kitt Emilie Østerlid, Dung-Yeh Wu, Francesca Nonne, Maria Rosaria Romano, Jeroen Codée & Roberto Adamo. (2022) Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. Chemical Reviews 122:20, pages 15672-15716.
Crossref
Crossref
Milou Ohm, Susan J M Hahné, Arie van der Ende, Elisabeth A M Sanders, Guy A M Berbers, Wilhelmina L M Ruijs, Nina M van Sorge, Hester E de Melker & Mirjam J Knol. (2022) Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study. Clinical Infectious Diseases 74:12, pages 2173-2180.
Crossref
Crossref
Arianna Neri, Massimo Fabiani, Anna Maria Barbui, Caterina Vocale, Alessandro Miglietta, Cecilia Fazio, Anna Carannante, Annapina Palmieri, Paola Vacca, Luigina Ambrosio & Paola Stefanelli. (2022) Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy. Vaccines 10:5, pages 778.
Crossref
Crossref
Clara Lehmann. (2022) Impfungen für das Immungedächtnis – immer wieder oder einmalig?Vaccinations for the immunologic memory—Repeatedly or once only?. Der Internist 63:5, pages 476-483.
Crossref
Crossref
Irene Rivero-Calle, Peter Francis Raguindin, Jacobo Pardo-Seco & Federico Martinon-Torres. (2022) Risk Analysis by Age on the Burden of Meningococcal Disease in Spain. Vaccines 10:4, pages 592.
Crossref
Crossref
Yara Ruiz Garcia, Véronique Abitbol, Michele Pellegrini, Rafik Bekkat-Berkani & Lamine Soumahoro. (2021) A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine. Infectious Diseases and Therapy 11:2, pages 639-655.
Crossref
Crossref
Hannah Gora, Simon Smith, Ian Wilson, Annie Preston-Thomas, Nicole Ramsamy & Josh Hanson. (2022) The epidemiology and outcomes of central nervous system infections in Far North Queensland, tropical Australia; 2000-2019. PLOS ONE 17:3, pages e0265410.
Crossref
Crossref
R. Villena, M.T. Valenzuela, M. Bastías & M.E. Santolaya. (2022) Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction. Vaccine 40:4, pages 666-672.
Crossref
Crossref
Francesco Berti, Maria Rosaria Romano, Francesca Micoli & Roberto Adamo. (2021) Carbohydrate based meningococcal vaccines: past and present overview. Glycoconjugate Journal 38:4, pages 401-409.
Crossref
Crossref
Mark McMillan, Bing Wang, Ann P Koehler, Thomas R Sullivan & Helen S Marshall. (2021) Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents. Clinical Infectious Diseases 73:1, pages e233-e237.
Crossref
Crossref
Henju Marjuki, How-Yi Chang, Nadav Topaz, Melissa J. Whaley, Jeni Vuong, Alexander Chen, Laurel T. Jenkins, Fang Hu, Susanna Schmink, Adam C. Retchless, Jennifer D. Thomas, Anna M. Acosta, Lucy A. McNamara, Heidi M. Soeters, Sarah Mbaeyi & Xin Wang. (2021) Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015–2016. mBio 12:3.
Crossref
Crossref
Supriya Sharma, Jyoti Acharya, Dominique A. Caugant, Shreedhar Aryal, Megha Raj Banjara, Prakash Ghimire & Anjana Singh. (2021) Meningococcal Carriage among Household Contacts of Patients with Invasive Meningococcal Disease in Kathmandu, Nepal: A Longitudinal Study. Pathogens 10:7, pages 781.
Crossref
Crossref
Judith E. Mueller. (2021) Stratégie vaccinale contre la Covid-19 au long terme : contrôle ou élimination ?. Actualité et dossier en santé publique N° 114:2, pages 5-9.
Crossref
Crossref
Jenny M MacLennan, Charlene M C Rodrigues, Holly B Bratcher, Aiswarya Lekshmi, Adam Finn, Jenny Oliver, Mandy Wootton, Samantha Ray, Claire Cameron, Andrew Smith, Paul T Heath, Angela Bartolf, Tracey Nolan, Stephen Hughes, Anu Varghese, Matthew D Snape, Richard Sewell, Richard Cunningham, Alison Stolton, Carole Kay, Karen Palmer, David Baxter, Debbie Suggitt, Christos S Zipitis, Nicola Pemberton, Keith A Jolley, James E Bray, Odile B Harrison, Shamez N Ladhani, Andrew J Pollard, Raymond Borrow, Stephen J Gray, Caroline Trotter & Martin C J Maiden. (2021) Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results. The Lancet Infectious Diseases 21:5, pages 677-687.
Crossref
Crossref
Paulo Gonçalves, Emma Sáez-López, Sofia Carneiro & Maria João Simões. (2021) Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme. PLOS ONE 16:4, pages e0250103.
Crossref
Crossref
Marcelle Moura Silveira, Pedro Augusto Crespo da Silva, Neida Lucia Conrad, Thaís Larré Oliveira, Daiane Drawanz Hartwig & Caroline Trotter. (2021) Surveillance of invasive meningococcal disease in the south of Brazil: considerations of immunization programme. Journal of Medical Microbiology 70:3.
Crossref
Crossref
Andrew J. Pollard & Else M. Bijker. (2020) A guide to vaccinology: from basic principles to new developments. Nature Reviews Immunology 21:2, pages 83-100.
Crossref
Crossref
Christian Jesberger & Stefan Greß. 2021. Public Health. Public Health
85
104
.
Federico Martinón-Torres. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
3
14
.
Myint Tin Tin Htar, Sally Jackson, Paul Balmer, Lidia Cristina Serra, Andrew Vyse, Mary Slack, Margarita Riera-Montes, David L. Swerdlow & Jamie Findlow. (2020) Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs. BMC Public Health 20:1.
Crossref
Crossref
Milou Ohm, Debbie M. van Rooijen, Axel A. Bonačić Marinović, Mariëtte B. van Ravenhorst, Marieke van der Heiden, Anne-Marie Buisman, Elisabeth A.M. Sanders & Guy A.M. Berbers. (2020) Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands. Vaccines 8:4, pages 624.
Crossref
Crossref
Jeremy Carr, Emma Plested, Parvinder Aley, Susana Camara, Kimberly Davis, Jenny M MacLennan, Steve Gray, Saul N Faust, Ray Borrow, Hannah Christensen, Caroline Trotter, Martin C J Maiden, Adam Finn & Matthew D Snape. (2020) ‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents. BMJ Open 10:10, pages e037358.
Crossref
Crossref
Cyra Patel, Clayton K Chiu, Frank H Beard, Nigel W Crawford & Kristine Macartney. (2020) One disease, two vaccines: challenges in prevention of meningococcal disease. Medical Journal of Australia 212:10, pages 453.
Crossref
Crossref
Peter J.A. Moore, B. Cherie Millar & John E. Moore. (2020) Meningococcal ACWY vaccine uptake and awareness among student freshers enrolled at Northern Ireland universities. International Journal of Adolescent Medicine and Health 32:1.
Crossref
Crossref
Helen S. MarshallMark McMillan, Ann P. KoehlerAndrew LawrenceThomas R. SullivanJenny M. MacLennanMartin C.J. Maiden, Shamez N. LadhaniMary E. RamsayCaroline TrotterRay BorrowAdam FinnCharlene M. KahlerJane WhelanKumaran VadiveluPeter Richmond. (2020) Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia. New England Journal of Medicine 382:4, pages 318-327.
Crossref
Crossref
Maria Cecília Gorla, Angela Pires Brandao, Juliana Maira Watanabe Pinhata, Camile de Moraes, Gabriela Pereira & Ana Paula Lemos. (2020) Phenotypic characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease in Brazil from 2002 to 2017. Access Microbiology 2:1.
Crossref
Crossref
J. Truong, C. Levy, S. Prot-Labarthe, H.P.K. Nguyen, E. Grimprel, A. Faye, R. Cohen & M. Lorrot. (2020) Vaccine-preventable meningitis in French children with incorrect vaccination status from 2011 to 2013. Archives de Pédiatrie 27:1, pages 1-5.
Crossref
Crossref
Juan Carlos Sanz Moreno & Belén Ramos Blázquez. (2019) Papel del estado de portador en el control de enfermedades infecciosas y su relación con la vacunación. Revista Madrileña de Salud Pública 2:10, pages 1-8.
Crossref
Crossref
R. Villena, M.T. Valenzuela, M. Bastías & M.E. Santolaya. (2019) Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile. Vaccine 37:46, pages 6915-6921.
Crossref
Crossref
José Francisco Santos-Neto, Viviane Matos Ferreira, Caroline Alves Feitosa, Martha Silvia Martinez-Silveira & Leila Carvalho Campos. (2019) Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review. The Brazilian Journal of Infectious Diseases 23:4, pages 254-267.
Crossref
Crossref
Robert M. Mulhall, Desiree E. Bennett, Holly B. Bratcher, Keith A. Jolley, James E. Bray, Piaras P. O’Lorcain, Suzanne M. Cotter, Martin C. J. Maiden & Robert J. Cunney. (2019) cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland. PLOS ONE 14:5, pages e0216771.
Crossref
Crossref
Diane Gbesemete, Jay Robert Laver, Hans de Graaf, Muktar Ibrahim, Andrew Vaughan, Saul Faust, Andrew Gorringe & Robert Charles Read. (2019)
Protocol for a controlled human infection with genetically modified
Neisseria lactamica
expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine
. BMJ Open 9:4, pages e026544.
Crossref
Crossref
Meagan E Peterson, You Li, Heather Shanks, Rebecca Mile, Harish Nair & Moe H Kyaw. (2019) Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis. BMJ Open 9:4, pages e024343.
Crossref
Crossref
Kirsten MA Trayner, Niall Anderson & J Claire Cameron. (2018) A mixed-methods study to identify factors associated with MenACWY vaccine uptake, barriers and motivations towards vaccination among undergraduate students. Health Education Journal 78:2, pages 189-202.
Crossref
Crossref
Brian M. Greenwood, Abraham Aseffa, Dominique A. Caugant, Kanny Diallo, Paul A. Kristiansen, Martin C. J. Maiden, James M. Stuart & Caroline L. Trotter. (2019)
Narrative review of methods and findings of recent studies on the carriage of meningococci and other
Neisseria
species in the African Meningitis Belt
. Tropical Medicine & International Health 24:2, pages 143-154.
Crossref
Crossref
Martin Christopher James Maiden. (2019) The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment. Frontiers in Immunology 9.
Crossref
Crossref
L. V. Cooper, P. A. Kristiansen, H. Christensen, A. Karachaliou & C. L. Trotter. (2019) Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis. Epidemiology and Infection 147.
Crossref
Crossref
D. Bennett, P. O'Lorcain, S. Morgan, S. Cotter, M. Cafferkey & R. Cunney. (2019) Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016. Epidemiology and Infection 147.
Crossref
Crossref
Elena Chiappini, Federica Inturrisi, Elisa Orlandini, Maurizio de Martino & Chiara de Waure. (2018) Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000–2016 period. BMC Infectious Diseases 18:1.
Crossref
Crossref
Meagan E. Peterson, Rebecca Mile, You Li, Harish Nair & Moe H. Kyaw. (2018) Meningococcal carriage in high-risk settings: A systematic review. International Journal of Infectious Diseases 73, pages 109-117.
Crossref
Crossref
Helen S Marshall, Mark McMillan, Ann Koehler, Andrew Lawrence, Jenny M MacLennan, Martin C J Maiden, Mary Ramsay, Shamez N Ladhani, Caroline Trotter, Ray Borrow, Adam Finn, Thomas Sullivan, Peter Richmond, Charlene M Kahler, Jane Whelan & Kumaran Vadivelu. (2018)
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of
Neisseria meningitidis
in adolescents
. BMJ Open 8:7, pages e020988.
Crossref
Crossref
Luis Rivera, Pornthep Chanthavanich, Airi Põder, P.V. Suryakiran, Archana Jastorff & Marie Van der Wielen. (2018) MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial. Vaccine 36:27, pages 3967-3975.
Crossref
Crossref
Holly B Bratcher, Carina Brehony, Sigrid Heuberger, Despo Pieridou-Bagatzouni, Pavla Křížová, Steen Hoffmann, Maija Toropainen, Muhamed-Kheir Taha, Heike Claus, Georgina Tzanakaki, Tímea Erdôsi, Jelena Galajeva, Arie van der Ende, Anna Skoczyńska, Marina Pana, Alena Vaculíková, Metka Paragi, Martin CJ Maiden & Dominique A Caugant. (2018) Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year. Eurosurveillance 23:20.
Crossref
Crossref
Al-Mamoon Badahdah, Ameneh Khatami, Mohamed Tashani, Harunor Rashid & Robert Booy. (2018) Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children. Pediatric Infectious Disease Journal 37:3, pages e66-e71.
Crossref
Crossref
Simon Sauvé, Geneviève Gingras & Yves Aubin. (2018) NMR study of mutations of glycine-52 of the catalytic domain of diphtheria toxin. Journal of Pharmaceutical and Biomedical Analysis 150, pages 72-79.
Crossref
Crossref
Neil J Oldfield, Luke R Green, Julian Parkhill, Christopher D Bayliss & David P J Turner. (2018) Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students. The Journal of Infectious Diseases 217:4, pages 608-616.
Crossref
Crossref
Charlene M. C. Rodrigues, Hannah Chan, Caroline Vipond, Keith Jolley, Odile B. Harrison, Jun Wheeler, Gail Whiting, Ian M. Feavers & Martin C. J. Maiden. (2019) Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens. Wellcome Open Research 3, pages 151.
Crossref
Crossref
Charlene M. C. Rodrigues, Hannah Chan, Caroline Vipond, Keith Jolley, Odile B. Harrison, Jun Wheeler, Gail Whiting, Ian M. Feavers & Martin C. J. Maiden. (2018) Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens. Wellcome Open Research 3, pages 151.
Crossref
Crossref
Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2018. Plotkin's Vaccines. Plotkin's Vaccines
644
662.e6
.
Lucy A McNamara, Jennifer Dolan Thomas, Jessica MacNeil, How Yi Chang, Michael Day, Emily Fisher, Stacey Martin, Tasha Poissant, Susanna E Schmink, Evelene Steward-Clark, Laurel T Jenkins, Xin Wang, Anna Acosta, Kristina Angelo, Amy Blain, Pam Cassiday, Shankar Changayil, Elizabeth Chandler Church, Kasey Diebold, Sinmisola Ewumi, Amanda Faulkner, Helen Fisun, Holly Haberman, Brian Harcourt, Sterling Haring, Lauren Hughes, Sandeep Joseph, Nivritti Kumaran, Adria Lee, Tanya Lennon, Ruth Link-Gelles, Lihan (Diana) Lu, Jessica Marcinkevage, Leonard Mayer, Jenny Milucky, Christine Miner, Jennifer Nelson, Manisha Patel, Simon Paulos, Veronica Pinell-McNamara, Conrad Quinn, Gowrisankar Rajam, Romany Redman, Adam Retchless, Mariana Rosenthal, Vera Semenova, Tami Skoff, Elizabeth Smulian, Toscha Stanley, Erin Stratton, Pam Talley, Tejpratep Tiwari, Karrie-Ann Toews, Matt Westercamp, Paul Cieslak, Malini DeSilva, Nick Alviani, Frances Biel, Bailey Burkhalter, Matt Francis, Phebe Howe, Esther Jackson, Tina Johnson, Patrick Luedtke, Zach Manning, Ester Muno, Todd Roberts, Zack Roberts, Michael Eyster & Charles Hollands. (2017) Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak—Oregon, 2015–2016. The Journal of Infectious Diseases 216:9, pages 1130-1140.
Crossref
Crossref
Jonathan Broad & Matthew D Snape. (2017) Where next? The emergence of hypervirulent W meningococcus in the Netherlands. The Lancet Public Health 2:10, pages e443-e444.
Crossref
Crossref
Marion Le Maréchal, Nelly Agrinier, Lisa Fressard, Pierre Verger & Céline Pulcini. (2017) Low Uptake of Meningococcal C Vaccination in France. Pediatric Infectious Disease Journal 36:7, pages e181-e188.
Crossref
Crossref
Philippe De Wals & Zhou Zhou. (2017) Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada. Pediatric Infectious Disease Journal 36:7, pages e203-e207.
Crossref
Crossref
Ian M. Feavers & Martin C. J. Maiden. (2017) Recent Progress in the Prevention of Serogroup B Meningococcal Disease. Clinical and Vaccine Immunology 24:5.
Crossref
Crossref
Lina Pérez-Breva, Raquel Abad-Torreblanca, Miguel Ángel Martínez-Beneito, Joan Puig-Barberà, Sara Alemán-Sánchez, Nuria Morant-Talamante, Macrina Sastre-Cantón, Julio A. Vázquez-Moreno & Javier Díez-Domingo. (2017) Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination. Vaccine 35:22, pages 2949-2954.
Crossref
Crossref
Jamie Findlow & Ray Borrow. (2017) Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?. Pathogens and Disease 75:2.
Crossref
Crossref
Susanne P. Stoof, Mariëtte B. van Ravenhorst, Debbie M. van Rooijen, Richarda M. de Voer, Fiona R. M. van der Klis, Greet J. Boland, Elisabeth A. M. Sanders, Guy A. M. Berbers & Peter F. Teunis. (2017) Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence. Clinical and Vaccine Immunology 24:2.
Crossref
Crossref
M. L. A. GONZALES, V. BIANCO & A. VYSE. (2016) Meningococcal carriage in children and young adults in the Philippines: a single group, cross-sectional study. Epidemiology and Infection 145:1, pages 126-132.
Crossref
Crossref
Robert C. Read, Peter Dull, Xilian Bai, Kate Nolan, Jamie Findlow, Rohit Bazaz, Annett Kleinschmidt, Maggie McCarthy, Huajun Wang, Daniela Toneatto & Ray Borrow. (2017) A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine. Vaccine 35:3, pages 427-434.
Crossref
Crossref
Federico Martinon-Torres. 2017. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
3
12
.
Kyriaki Tryfinopoulou, Konstantinos Kesanopoulos, Athanasia Xirogianni, Nektarios Marmaras, Anastasia Papandreou, Vassiliki Papaevangelou, Maria Tsolia, Aftab Jasir & Georgina Tzanakaki. (2016) Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015). PLOS ONE 11:12, pages e0167404.
Crossref
Crossref
Desirée Morales, Manuel García-Cenoz, Laura Moreno, Enrique Bernaola, Aurelio Barricarte & Jesús Castilla. (2016) Vacuna conjugada frente al meningococo C: impacto del programa de vacunación y efectividad a largo plazo en Navarra, 2000-2014. Enfermedades Infecciosas y Microbiología Clínica 34:10, pages 639-644.
Crossref
Crossref
Amélia Maria Pithon Borges Nunes, Guilherme Sousa Ribeiro, Ítalo Eustáquio Ferreira, Ana Rafaela Silva Simões Moura, Ridalva Dias Martins Felzemburgh, Ana Paula Silva de Lemos, Mitermayer Galvão Reis, José Cassio de Moraes & Leila Carvalho Campos. (2016) Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil. PLOS ONE 11:11, pages e0166475.
Crossref
Crossref
Ray Borrow, Jin-Soo Lee, Julio A. Vázquez, Godwin Enwere, Muhamed-Kheir Taha, Hajime Kamiya, Hwang Min Kim & Dae Sun Jo. (2016) Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative. Vaccine 34:48, pages 5855-5862.
Crossref
Crossref
Edmund Loh, Hayley Lavender, Felicia Tan, Alexander Tracy & Christoph M. Tang. (2016) Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame. PLOS Pathogens 12:8, pages e1005794.
Crossref
Crossref
G. K. Bårnes, B. Workalemahu, P. A. Kristiansen, D. Beyene, B. Merdekios, P. Fissiha, A. Aseffa, D. A. Caugant & L. M. Næss. (2016)
Salivary and Serum Antibody Response Against
Neisseria meningitidis
After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers
. Scandinavian Journal of Immunology 84:2, pages 118-129.
Crossref
Crossref
Moataz Abd El Ghany, Hazem Sharaf & Grant A. Hill-Cawthorne. (2016) Hajj vaccinations—facts, challenges, and hope. International Journal of Infectious Diseases 47, pages 29-37.
Crossref
Crossref
Rosália Garcia Neves, Andrea Wendt Böhm, Caroline dos Santos Costa, Thaynã Ramos Flores, Ana Luiza Gonçalves Soares & Fernando César Wehrmeister. (2016) Cobertura da vacina meningocócica C nos estados e regiões do Brasil em 2012. Revista Brasileira de Medicina de Família e Comunidade 11:38, pages 1-10.
Crossref
Crossref
Irene Rivero-Calle, Lucia Vilanova-Trillo, Jacobo Pardo-Seco, Lidia Blanco Salvado, Laura Illade Quinteiro & Federico Martinon-Torres. (2016) The Burden of Pediatric Invasive Meningococcal Disease in Spain (2008–2013). Pediatric Infectious Disease Journal 35:4, pages 407-413.
Crossref
Crossref
C. Hal Jones, Naglaa Mohamed, Eduardo Rojas, Lubomira Andrew, Johanna Hoyos, Julio C. Hawkins, Lisa K. McNeil, Qin Jiang, Leonard W. Mayer, Xin Wang, Rodica Gilca, Philippe De Wals, Louise Pedneault, Joseph Eiden, Kathrin U. Jansen & Annaliesa S. Anderson. (2016) Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections. Journal of Clinical Microbiology 54:1, pages 25-34.
Crossref
Crossref
Caroline L. Trotter & Martin C. J. Maiden. 2016. Handbook of Meningococcal Disease Management. Handbook of Meningococcal Disease Management
15
23
.
Andrew R Gorringe. (2016) The difficult road to new vaccines for pertussis and serogroup B meningococcal disease. Journal of Chemical Technology & Biotechnology 91:1, pages 9-15.
Crossref
Crossref
Charissa Fay Corazon Borja-Tabora, Cecilia Montalban, Ziad A. Memish, Dominique Boutriau, Devayani Kolhe, Jacqueline M. Miller & Marie Van der Wielen. (2015) Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial. BMC Infectious Diseases 15:1.
Crossref
Crossref
Timo Vesikari, Aino Forsten, Veronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2015) Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines. Pediatric Infectious Disease Journal 34:12, pages e298-e307.
Crossref
Crossref
R. Cohen, F. Vie Le Sage & E. Grimprel. (2015) Info-vaccins. Archives de Pédiatrie 22:12, pages 1309-1311.
Crossref
Crossref
Jose Cassio de Moraes, Brigina Kemp, Ana Paula Silva de Lemos, Maria Cecilia Outeiro Gorla, Eneida Gonçalves Lemes Marques, Maria do Carmo Ferreira, Claudio Sacchi, Telma Regina Marques Pinto Carvalhanas, Ana Freitas Ribeiro, Cleide Marques Ferreira, Maristela Marques Salgado, Lucila Fukasawa, Maria Gisele Gonçalves, Fabio Higa, Rodrigo Angerami, André Ribas Freitas, Helena Keico Sato & Marco Aurélio Palazzi Sáfadi. (2015) Prevalence, Risk Factors and Molecular Characteristics of Meningococcal Carriage Among Brazilian Adolescents. Pediatric Infectious Disease Journal 34:11, pages 1197-1202.
Crossref
Crossref
Susanne P. Stoof, Gerwin D. Rodenburg, Mirjam J. Knol, Lidewij W. Rümke, Sandra Bovenkerk, Guy A. M. Berbers, Lodewijk Spanjaard, Arie van der Ende & Elisabeth A. M. Sanders. (2015) Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex. Clinical Infectious Diseases 61:8, pages 1281-1292.
Crossref
Crossref
Ingrid L Scully, Kena Swanson, Luke Green, Kathrin U Jansen & Annaliesa S Anderson. (2015) Anti-infective vaccination in the 21st century—new horizons for personal and public health. Current Opinion in Microbiology 27, pages 96-102.
Crossref
Crossref
Eduardo Rojas, Johanna Hoyos, Neil J. Oldfield, Philip Lee, Mike Flint, C. Hal Jones, Dlawer A. A. Ala’Aldeen, Kathrin U. Jansen & Annaliesa S. Anderson. (2015) Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines. PLOS ONE 10:7, pages e0132140.
Crossref
Crossref
Susanne P. Stoof, Fiona R.M. van der Klis, Debbie M. van Rooijen, Debby Bogaert, Krzysztof Trzciński, Elisabeth A.M. Sanders & Guy A.M. Berbers. (2015) Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool. Vaccine 33:32, pages 3933-3939.
Crossref
Crossref
Alice M. Deasy, Ed Guccione, Adam P. Dale, Nick Andrews, Cariad M. Evans, Julia S. Bennett, Holly B. Bratcher, Martin C. J. Maiden, Andrew R. Gorringe & Robert C. Read. (2015) Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study. Clinical Infectious Diseases 60:10, pages 1512-1520.
Crossref
Crossref
Ana Cristina C. Frota, Lucimar G. Milagres, Lee H. Harrison, Bianca Ferreira, Daniela Menna Barreto, Gisele S. Pereira, Aline C. Cruz, Wania Pereira-Manfro, Ricardo Hugo de Oliveira, Thalita F. Abreu & Cristina B. Hofer. (2015) Immunogenicity and Safety of Meningococcal C Conjugate Vaccine in Children and Adolescents Infected and Uninfected with HIV in Rio de Janeiro, Brazil. Pediatric Infectious Disease Journal 34:5, pages e113-e118.
Crossref
Crossref
Marcello Tirani, Michela Meregaglia & Alessia Melegaro. (2015) Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme. PLOS ONE 10:4, pages e0123383.
Crossref
Crossref
David M. Vickers, Andrea M. Anonychuk, Philippe De Wals, Nadia Demarteau & Chris T. Bauch. (2015) Evaluation of serogroup C and ACWY meningococcal vaccine programs: Projected impact on disease burden according to a stochastic two-strain dynamic model. Vaccine 33:1, pages 268-275.
Crossref
Crossref
David S. Stephens & Michael A. Apicella. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
2425
2445.e6
.
Franck Thollot, David Scheifele, Heidemarie Pankow-Culot, Brigitte Cheuvart, Maarten Leyssen, Liliana Ulianov & Jacqueline M. Miller. (2014) A Randomized Study to Evaluate the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus influenzae b, and Meningococcal Serogroup C Combination Vaccine Administered to Infants at 2, 4 and 12 Months of Age. Pediatric Infectious Disease Journal 33:12, pages 1246-1254.
Crossref
Crossref
Matthew J. Ferrari, Florence Fermon, Fabienne Nackers, Augusto Llosa, Claire Magone & Rebecca F. Grais. (2014) Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria. International Health 6:4, pages 282-290.
Crossref
Crossref
Robert C Read, David Baxter, David R Chadwick, Saul N Faust, Adam Finn, Stephen B Gordon, Paul T Heath, David J M Lewis, Andrew J Pollard, David P J Turner, Rohit Bazaz, Amitava Ganguli, Tom Havelock, Keith R Neal, Ifeanyichukwu O Okike, Begonia Morales-Aza, Kamlesh Patel, Matthew D Snape, John Williams, Stefanie Gilchrist, Steve J Gray, Martin C J Maiden, Daniela Toneatto, Huajun Wang, Maggie McCarthy, Peter M Dull & Ray Borrow. (2014) Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. The Lancet 384:9960, pages 2123-2131.
Crossref
Crossref
Merijn W. Bijlsma, Matthijs C. Brouwer, Lodewijk Spanjaard, Diederik van de Beek & Arie van der Ende. (2014) A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination. Clinical Infectious Diseases 59:9, pages 1216-1221.
Crossref
Crossref
J. HUELS, K. M. CLEMENTS, L. J. McGARRY, G. J. HILL, J. WASSIL & S. KESSABI. (2013)
Modelled evaluation of multi-component meningococcal vaccine (Bexsero
®
) for the prevention of invasive meningococcal disease in infants and adolescents in the UK
. Epidemiology and Infection 142:9, pages 2000-2012.
Crossref
Crossref
Linda Jonker & Ethelwynn L. Stellenberg. (2014) Missed opportunities in child healthcare. African Journal of Primary Health Care & Family Medicine 6:1.
Crossref
Crossref
Susanne P. Stoof, Fiona R. M. van der Klis, Debbie M. van Rooijen, Mirjam J. Knol, Elisabeth A. M. Sanders & Guy A. M. Berbers. (2014) Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers. PLoS ONE 9:6, pages e100651.
Crossref
Crossref
Roberto Gasparini, Maurizio Comanducci, Daniela Amicizia, Filippo Ansaldi, Paola Canepa, Andrea Orsi, Giancarlo Icardi, Emanuela Rizzitelli, Gabriella De Angelis, Stefania Bambini, Monica Moschioni, Sara Comandi, Isabella Simmini, Giueseppe Boccadifuoco, Brunella Brunelli, Marzia Monica Giuliani, Mariagrazia Pizza & Donatella Panatto. (2014) Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years. Journal of Clinical Microbiology 52:6, pages 1901-1910.
Crossref
Crossref
Marco Aurelio Palazzi Sáfadi, Telma Regina Marques Pinto Carvalhanas, Ana Paula de Lemos, Maria Cecilia Outeiro Gorla, Maristela Salgado, Lucila O. Fukasawa, Maria Gisele Gonçalves, Fabio Higa, Maria Cristina Cunto Brandileone, Claudio Tavares Sacchi, Ana Freitas Ribeiro, Helena Keico Sato, Lucia Ferro Bricks & José Cassio de Moraes. (2014) Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010. Emerging Infectious Diseases 20:5, pages 806-811.
Crossref
Crossref
Ricardo Walter Rüttimann, Angela Gentile, Mercedes Macias Parra, Xavier Saez-Llorens, Marco Aurelio Palazzi Safadi & Maria Elena Santolaya. (2014) A Consensus Statement. Pediatric Infectious Disease Journal 33:3, pages 284-290.
Crossref
Crossref
D. Moreno-Pérez, F.J. Álvarez García, J. Arístegui Fernández, M.J. Cilleruelo Ortega, J.M. Corretger Rauet, N. García Sánchez, A. Hernández Merino, T. Hernández-Sampelayo Matos, M. Merino Moína, L. Ortigosa del Castillo & J. Ruiz-Contreras. (2014) Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2014. Vacunas 15:1-2, pages 37-62.
Crossref
Crossref
D. Moreno-Pérez, F.J. Álvarez García, J. Arístegui Fernández, M.J. Cilleruelo Ortega, J.M. Corretger Rauet, N. García Sánchez, A. Hernández Merino, T. Hernández-Sampelayo Matos, M. Merino Moína, L. Ortigosa del Castillo & J. Ruiz-Contreras. (2014) Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2014. Anales de Pediatría 80:1, pages 55.e1-55.e37.
Crossref
Crossref
Charissa Borja-Tabora, Cecilia Montalban, Ziad A Memish, Marie Van der Wielen, Veronique Bianco, Dominique Boutriau & Jacqueline Miller. (2013) Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study. BMC Infectious Diseases 13:1.
Crossref
Crossref
Pere Domingo, Virginia Pomar, Natividad de Benito & Pere Coll. (2013) The spectrum of acute bacterial meningitis in elderly patients. BMC Infectious Diseases 13:1.
Crossref
Crossref
Ray Borrow, Raquel Abad, Caroline Trotter, Fiona R.M. van der Klis & Julio A. Vazquez. (2013) Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine 31:41, pages 4477-4486.
Crossref
Crossref
Martin C. J. Maiden. (2013) The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?. Philosophical Transactions of the Royal Society B: Biological Sciences 368:1623, pages 20120147.
Crossref
Crossref
Kay O. Johswich, Shannon E. McCaw, Epshita Islam, Anna Sintsova, Angel Gu, John E. Shively & Scott D. Gray-Owen. (2013) In Vivo Adaptation and Persistence of Neisseria meningitidis within the Nasopharyngeal Mucosa. PLoS Pathogens 9:7, pages e1003509.
Crossref
Crossref
Andrea Anonychuk, Gloria Woo, Andrew Vyse, Nadia Demarteau & Andrea C. Tricco. (2013) The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review. PharmacoEconomics 31:7, pages 563-576.
Crossref
Crossref
Lisa K. McNeil, Robert J. Zagursky, Shuo L. Lin, Ellen Murphy, Gary W. Zlotnick, Susan K. Hoiseth, Kathrin U. Jansen & Annaliesa S. Anderson. (2013) Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease. Microbiology and Molecular Biology Reviews 77:2, pages 234-252.
Crossref
Crossref
Hiltsje Hepkema, Koen B. Pouwels, Arie van der Ende, Tjalke A. Westra & Maarten J. Postma. (2013) Meningococcal Serogroup A, C, W135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands. PLoS ONE 8:5, pages e65036.
Crossref
Crossref
Hannah Christensen, Matthew Hickman, W. John Edmunds & Caroline L. Trotter. (2013) Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact. Vaccine 31:23, pages 2638-2646.
Crossref
Crossref
Ghassan Dbaibo, Nabil El-Ayoubi, Soha Ghanem, Farah Hajar, Veronique Bianco, Jacqueline M. Miller & Narcisa Mesaros. (2013) Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial. Drugs & Aging 30:5, pages 309-319.
Crossref
Crossref
Helen Findlow & Ray Borrow. (2013) Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT. Advances in Therapy 30:5, pages 431-458.
Crossref
Crossref
M. A. P. SÁFADI, S. GONZÁLEZ-AYALA, A. JÄKEL, H. WIEFFER, C. MORENO & A. VYSE. (2012) The epidemiology of meningococcal disease in Latin America 1945–2010: an unpredictable and changing landscape. Epidemiology and Infection 141:3, pages 447-458.
Crossref
Crossref
Tzu-Wei Wu, Hans Hsienhong Lin & Li-Yu Wang. (2013) Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology 57:1, pages 37-45.
Crossref
Crossref
Jamie D. Croxtall & Sohita Dhillon. (2012) Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™). Drugs 72:18, pages 2407-2430.
Crossref
Crossref
Angela Bechini, Miriam Levi, Sara Boccalini, Emilia Tiscione, Emanuela Balocchini, Clementina Canessa, Chiara Azzari & Paolo Bonanni. (2012) Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy. Vaccine 30:45, pages 6396-6401.
Crossref
Crossref
Ryan T Novak, Jean Ludovic Kambou, Fabien VK Diomandé, Tiga F Tarbangdo, Rasmata Ouédraogo-Traoré, Lassana Sangaré, Clement Lingani, Stacey W Martin, Cynthia Hatcher, Leonard W Mayer, F Marc LaForce, Fenella Avokey, Mamoudou H Djingarey, Nancy E Messonnier, Sylvestre R Tiendrébéogo & Thomas A Clark. (2012) Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. The Lancet Infectious Diseases 12:10, pages 757-764.
Crossref
Crossref
D. Gendrel. (2012) Vaccins anti-méningococciques: des politiques vaccinales et des recommandations hétérogènes. Archives de Pédiatrie 19, pages S70-S76.
Crossref
Crossref
Mehmet Ceyhan, Sameh Anis, Latt Htun-Myint, Robert Pawinski, Montse Soriano-Gabarró & Andrew Vyse. (2012) Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attention. International Journal of Infectious Diseases 16:8, pages e574-e582.
Crossref
Crossref
Harunor Rashid, Gulam Khandaker & Robert Booy. (2012) Vaccination and herd immunity. Current Opinion in Infectious Diseases 25:3, pages 243-249.
Crossref
Crossref
Julie A. Bettinger, David W. Scheifele, Scott A. Halperin, James D. Kellner, Otto G. Vanderkooi, Anthony Schryvers, Gaston De Serres & Joenel Alcantara. (2012) Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis. Vaccine 30:27, pages 4023-4027.
Crossref
Crossref
Martin C.J. Maiden & Matthias Frosch. (2012) Can we, should we, eradicate the meningococcus?. Vaccine 30, pages B52-B56.
Crossref
Crossref
Lucia H. Lee & Milan S. Blake. (2012)
Effect of Increased CRM
197
Carrier Protein Dose on Meningococcal C Bactericidal Antibody Response
. Clinical and Vaccine Immunology 19:4, pages 551-556.
Crossref
Crossref
Mariagrazia Pizza, Lisa DeTora & James Wassil. (2012) Advances in meningococcal vaccines. Clinical Practice 9:1, pages 101-117.
Crossref
Crossref
Jodie McVernon, Terry Nolan, Peter Richmond, Graham Reynolds, Michael Nissen, Stephen B. Lambert, Helen Marshall, Thomas Papa & Christine Rehm. (2012) A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers. Pediatric Infectious Disease Journal 31:1, pages e15-e23.
Crossref
Crossref
Ana Belén Ibarz-Pavón, Jenny MacLennan, Nicholas J. Andrews, Stephen J. Gray, Rachel Urwin, Stuart C. Clarke, A. Mark Walker, Meirion R. Evans, J. Simon Kroll, Keith R. Neal, Dlawer Ala'Aldeen, Derrick W. Crook, Kathryn Cann, Sarah Harrison, Richard Cunningham, David Baxter, Edward Kaczmarski, Noel D. McCarthy, Keith A. Jolley, J. Claire Cameron, James M. Stuart & Martin C. J. Maiden. (2011) Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation. The Journal of Infectious Diseases 204:7, pages 1046-1053.
Crossref
Crossref
Jane W. Marsh, Kathleen A. Shutt, Rolando Pajon, Mary M. Tulenko, Stephen Liu, Rosemary A. Hollick, Julia A. Kiehlbauch, Thomas A. Clark, David S. Stephens, Kathryn E. Arnold, Robert A. Myers, Leonard W. Mayer & Lee H. Harrison. (2011) Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates. Vaccine 29:35, pages 6049-6058.
Crossref
Crossref
Philippe De Wals, Geneviève Deceuninck, Brigitte Lefebvre, Nicole Boulianne & Gaston De Serres. (2011) Effectiveness of Serogroup C Meningococcal Conjugate Vaccine. Pediatric Infectious Disease Journal 30:7, pages 566-569.
Crossref
Crossref
Michael Bröker, Paolo Costantino, Lisa DeTora, E. David McIntosh & Rino Rappuoli. (2011) Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications. Biologicals 39:4, pages 195-204.
Crossref
Crossref
E Richard Moxon & Claire-Anne Siegrist. (2011) The next decade of vaccines: societal and scientific challenges. The Lancet 378:9788, pages 348-359.
Crossref
Crossref
Jessica R. MacNeil, Amanda C. Cohn, Elizabeth R. Zell, Susanna Schmink, Elaine Miller, Thomas Clark & Nancy E. Messonnier. (2011) Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine. Pediatric Infectious Disease Journal 30:6, pages 451-455.
Crossref
Crossref
James B. Wing, Lynne Smart, Ray Borrow, Jamie Findlow, Helen Findlow, Andrew W. Heath & Robert C. Read. (2011) Kinetics of Immune Responses to Nasal Challenge With Meningococcal Polysaccharide One Year After Serogroup-C Glycoconjugate Vaccination. Clinical Infectious Diseases 52:11, pages 1317-1323.
Crossref
Crossref
Keith L. Davis, Timothy J. Bell, Jacqueline M. Miller, Derek A. Misurski & Bela Bapat. (2011) Hospital Costs, Length of Stay and Mortality Associated with Childhood, Adolescent and Young Adult Meningococcal Disease in the US. Applied Health Economics and Health Policy 9:3, pages 197-207.
Crossref
Crossref
Mark Jit & Marc Brisson. (2011) Modelling the Epidemiology of Infectious Diseases for Decision Analysis. PharmacoEconomics 29:5, pages 371-386.
Crossref
Crossref
Hannah Christensen, Margaret May, Leah Bowen, Matthew Hickman & Caroline L Trotter. (2010) Meningococcal carriage by age: a systematic review and meta-analysis. The Lancet Infectious Diseases 10:12, pages 853-861.
Crossref
Crossref
Teresa L. Kauf. (2010) Methodological Concerns with Economic Evaluations of Meningococcal Vaccines. PharmacoEconomics 28:6, pages 449-461.
Crossref
Crossref
Neil RavenscroftJun X Wheeler & Christopher Jones. (2010) Bioanalysis of meningococcal vaccines. Bioanalysis 2:2, pages 343-361.
Crossref
Crossref